Drug group chief Pascal Soriot frustrated with UK but shareholders worry about country losing FTSE’s largest company
Ministers remain locked in talks with sector over future of clawback tax
Partnership gives group access to CSPC’s AI platform for discovering and optimising treatments
Pharma group estimates Camizestrant could be worth up to $5bn of sales in its peak year
Anglo-Swedish pharma company’s first-quarter earnings boosted by strong demand for cancer drugs
Trump’s tariffs have prompted businesses across the pond to question ties that have bound them to the US
London-listed drugmaker will establish research centre in Beijing
London-listed pharmaceuticals group expands investments in cancer cell therapies with EsoBiotec acquisition
Lawsuit claims UK pharma giant understated the risk of government investigations
How an agreement set up by the Tories and lauded by Labour fell victim to cost-cutting and UK curbs on drugs expenditure
FTSE’s most valuable company faces potential fine over suspected unpaid taxes in country
On supercomputers and life sciences, listening to Treasury naysayers risks letting work and political capital slip away
UK company raised NHS rejection of its new breast cancer drug and drug pricing mechanism during negotiations
Decision is a blow to Starmer’s government after setting out pro-growth pitch to investors
Arrest of FTSE 100 pharma group’s country president last year is expected to hit sales
FTSE 100 group reportedly faces difficulties in selling drugs to Chinese hospitals
Company veteran Iskra Reic moves to Shanghai after Leon Wang placed under investigation by authorities
The UK pharmaceutical company needs to resolve a corruption crackdown affecting senior executives
UK’s largest drugmaker to invest $3.5bn by end of 2026 as it targets doubling of revenues
Pharma group needs some good news to ease investors’ nerves
Pharmaceutical group confirms four other current and ex-executives investigated, in addition to Leon Wang
Investigation of group’s China chief Leon Wang comes after several employees were found guilty of fraud
British drugmaker says Leon Wang is ‘co-operating with an ongoing investigation’
Latest setback for Dato-DXd comes after disappointing results in lung cancer treatment earlier this month
Results offer hope of progress in combating bladder tumours and some forms of breast cancer
